Anti-inflammatory effects of betaine on AOM/DSS‑induced colon tumorigenesis in ICR male mice. 2014

Dong Hwan Kim, and Bokyung Sung, and Yong Jung Kang, and Jung Yoon Jang, and Seong Yeon Hwang, and Yujin Lee, and Minjung Kim, and Eunok Im, and Jeong-Hyun Yoon, and Cheol Min Kim, and Hae Young Chung, and Nam Deuk Kim
Department of Pharmacy, Molecular Inflammation Research Center for Aging Intervention, Pusan National University, Busan 609‑735, Republic of Korea.

Betaine is an important human nutrient obtained from various foods and studies in animals and humans have provided results suggesting their pathogenesis of various chronic diseases and points to a role in risk assessment and disease prevention. However, the molecular mechanisms of its activity remain poorly understood and warrant further investigation. This study was performed to investigate the anti-inflammation and tumor preventing capacity of betaine on colitis-associated cancer in mice. In in vivo experiments, we induced colon tumors in mice by azoxymethane (AOM) and dextran sulfate sodium (DSS) and evaluated the effects of betaine on tumor growth. Administration with betaine significantly decreased the incidence of tumor formation with downregulation of inflammation. Treatment with betaine inhibited ROS generation and GSSG concentration in colonic mucosa. Based on the qPCR data, administration of betaine inhibited inflammatory cytokines such TNF-α, IL-6, iNOS and COX-2. In in vitro experiments, LPS-induced NF-κB and inflammatory-related cytokines were inhibited by betaine treatment in RAW 264.7 murine macrophage cells. Our findings suggest that betaine is one of the candidates for the prevention of inflammation-associated colon carcinogenesis.

UI MeSH Term Description Entries
D008264 Macrophages The relatively long-lived phagocytic cell of mammalian tissues that are derived from blood MONOCYTES. Main types are PERITONEAL MACROPHAGES; ALVEOLAR MACROPHAGES; HISTIOCYTES; KUPFFER CELLS of the liver; and OSTEOCLASTS. They may further differentiate within chronic inflammatory lesions to EPITHELIOID CELLS or may fuse to form FOREIGN BODY GIANT CELLS or LANGHANS GIANT CELLS. (from The Dictionary of Cell Biology, Lackie and Dow, 3rd ed.) Bone Marrow-Derived Macrophages,Monocyte-Derived Macrophages,Macrophage,Macrophages, Monocyte-Derived,Bone Marrow Derived Macrophages,Bone Marrow-Derived Macrophage,Macrophage, Bone Marrow-Derived,Macrophage, Monocyte-Derived,Macrophages, Bone Marrow-Derived,Macrophages, Monocyte Derived,Monocyte Derived Macrophages,Monocyte-Derived Macrophage
D008297 Male Males
D008813 Mice, Inbred ICR An inbred strain of mouse that is used as a general purpose research strain, for therapeutic drug testing, and for the genetic analysis of CARCINOGEN-induced COLON CANCER. Mice, Inbred ICRC,Mice, ICR,Mouse, ICR,Mouse, Inbred ICR,Mouse, Inbred ICRC,ICR Mice,ICR Mice, Inbred,ICR Mouse,ICR Mouse, Inbred,ICRC Mice, Inbred,ICRC Mouse, Inbred,Inbred ICR Mice,Inbred ICR Mouse,Inbred ICRC Mice,Inbred ICRC Mouse
D002460 Cell Line Established cell cultures that have the potential to propagate indefinitely. Cell Lines,Line, Cell,Lines, Cell
D003092 Colitis Inflammation of the COLON section of the large intestine (INTESTINE, LARGE), usually with symptoms such as DIARRHEA (often with blood and mucus), ABDOMINAL PAIN, and FEVER. Colitides
D003110 Colonic Neoplasms Tumors or cancer of the COLON. Cancer of Colon,Colon Adenocarcinoma,Colon Cancer,Cancer of the Colon,Colon Neoplasms,Colonic Cancer,Neoplasms, Colonic,Adenocarcinoma, Colon,Adenocarcinomas, Colon,Cancer, Colon,Cancer, Colonic,Cancers, Colon,Cancers, Colonic,Colon Adenocarcinomas,Colon Cancers,Colon Neoplasm,Colonic Cancers,Colonic Neoplasm,Neoplasm, Colon,Neoplasm, Colonic,Neoplasms, Colon
D005978 Glutathione A tripeptide with many roles in cells. It conjugates to drugs to make them more soluble for excretion, is a cofactor for some enzymes, is involved in protein disulfide bond rearrangement and reduces peroxides. Reduced Glutathione,gamma-L-Glu-L-Cys-Gly,gamma-L-Glutamyl-L-Cysteinylglycine,Glutathione, Reduced,gamma L Glu L Cys Gly,gamma L Glutamyl L Cysteinylglycine
D006801 Humans Members of the species Homo sapiens. Homo sapiens,Man (Taxonomy),Human,Man, Modern,Modern Man
D000818 Animals Unicellular or multicellular, heterotrophic organisms, that have sensation and the power of voluntary movement. Under the older five kingdom paradigm, Animalia was one of the kingdoms. Under the modern three domain model, Animalia represents one of the many groups in the domain EUKARYOTA. Animal,Metazoa,Animalia
D000893 Anti-Inflammatory Agents Substances that reduce or suppress INFLAMMATION. Anti-Inflammatory Agent,Antiinflammatory Agent,Agents, Anti-Inflammatory,Agents, Antiinflammatory,Anti-Inflammatories,Antiinflammatories,Antiinflammatory Agents,Agent, Anti-Inflammatory,Agent, Antiinflammatory,Agents, Anti Inflammatory,Anti Inflammatories,Anti Inflammatory Agent,Anti Inflammatory Agents

Related Publications

Dong Hwan Kim, and Bokyung Sung, and Yong Jung Kang, and Jung Yoon Jang, and Seong Yeon Hwang, and Yujin Lee, and Minjung Kim, and Eunok Im, and Jeong-Hyun Yoon, and Cheol Min Kim, and Hae Young Chung, and Nam Deuk Kim
January 2020, Journal of immunology research,
Dong Hwan Kim, and Bokyung Sung, and Yong Jung Kang, and Jung Yoon Jang, and Seong Yeon Hwang, and Yujin Lee, and Minjung Kim, and Eunok Im, and Jeong-Hyun Yoon, and Cheol Min Kim, and Hae Young Chung, and Nam Deuk Kim
January 2024, Biochemical and biophysical research communications,
Dong Hwan Kim, and Bokyung Sung, and Yong Jung Kang, and Jung Yoon Jang, and Seong Yeon Hwang, and Yujin Lee, and Minjung Kim, and Eunok Im, and Jeong-Hyun Yoon, and Cheol Min Kim, and Hae Young Chung, and Nam Deuk Kim
January 2008, In vivo (Athens, Greece),
Dong Hwan Kim, and Bokyung Sung, and Yong Jung Kang, and Jung Yoon Jang, and Seong Yeon Hwang, and Yujin Lee, and Minjung Kim, and Eunok Im, and Jeong-Hyun Yoon, and Cheol Min Kim, and Hae Young Chung, and Nam Deuk Kim
January 2013, PloS one,
Dong Hwan Kim, and Bokyung Sung, and Yong Jung Kang, and Jung Yoon Jang, and Seong Yeon Hwang, and Yujin Lee, and Minjung Kim, and Eunok Im, and Jeong-Hyun Yoon, and Cheol Min Kim, and Hae Young Chung, and Nam Deuk Kim
September 2017, Molecular nutrition & food research,
Dong Hwan Kim, and Bokyung Sung, and Yong Jung Kang, and Jung Yoon Jang, and Seong Yeon Hwang, and Yujin Lee, and Minjung Kim, and Eunok Im, and Jeong-Hyun Yoon, and Cheol Min Kim, and Hae Young Chung, and Nam Deuk Kim
January 2024, Nutrition and cancer,
Dong Hwan Kim, and Bokyung Sung, and Yong Jung Kang, and Jung Yoon Jang, and Seong Yeon Hwang, and Yujin Lee, and Minjung Kim, and Eunok Im, and Jeong-Hyun Yoon, and Cheol Min Kim, and Hae Young Chung, and Nam Deuk Kim
January 2022, Frontiers in pharmacology,
Dong Hwan Kim, and Bokyung Sung, and Yong Jung Kang, and Jung Yoon Jang, and Seong Yeon Hwang, and Yujin Lee, and Minjung Kim, and Eunok Im, and Jeong-Hyun Yoon, and Cheol Min Kim, and Hae Young Chung, and Nam Deuk Kim
January 2023, Anti-cancer agents in medicinal chemistry,
Dong Hwan Kim, and Bokyung Sung, and Yong Jung Kang, and Jung Yoon Jang, and Seong Yeon Hwang, and Yujin Lee, and Minjung Kim, and Eunok Im, and Jeong-Hyun Yoon, and Cheol Min Kim, and Hae Young Chung, and Nam Deuk Kim
December 2021, Pharmaceutical biology,
Dong Hwan Kim, and Bokyung Sung, and Yong Jung Kang, and Jung Yoon Jang, and Seong Yeon Hwang, and Yujin Lee, and Minjung Kim, and Eunok Im, and Jeong-Hyun Yoon, and Cheol Min Kim, and Hae Young Chung, and Nam Deuk Kim
June 2023, Plants (Basel, Switzerland),
Copied contents to your clipboard!